TN2009000211A1 - Antiviral composition and method of use - Google Patents

Antiviral composition and method of use

Info

Publication number
TN2009000211A1
TN2009000211A1 TNP2009000211A TN2009000211A TN2009000211A1 TN 2009000211 A1 TN2009000211 A1 TN 2009000211A1 TN P2009000211 A TNP2009000211 A TN P2009000211A TN 2009000211 A TN2009000211 A TN 2009000211A TN 2009000211 A1 TN2009000211 A1 TN 2009000211A1
Authority
TN
Tunisia
Prior art keywords
antiviral composition
lambdacarrageenan
iota
kappa
prophylaxis
Prior art date
Application number
TNP2009000211A
Other languages
English (en)
Inventor
Andreas Grassauer
Eva Prieschl-Grassauer
Christiane Meier
Alexander Pretsch
Original Assignee
Marinomed Biotechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/567,078 external-priority patent/US20080131454A1/en
Priority claimed from EP06450176A external-priority patent/EP1930015A1/fr
Application filed by Marinomed Biotechnologie Gmbh filed Critical Marinomed Biotechnologie Gmbh
Publication of TN2009000211A1 publication Critical patent/TN2009000211A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Paper (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
TNP2009000211A 2006-12-05 2009-05-29 Antiviral composition and method of use TN2009000211A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/567,078 US20080131454A1 (en) 2006-12-05 2006-12-05 Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
EP06450176A EP1930015A1 (fr) 2006-12-05 2006-12-05 Utilisation de carraghénine pour traiter les infections causées par le rhinovirus
PCT/EP2007/010512 WO2008067982A2 (fr) 2006-12-05 2007-12-04 Composition antivirale et procédé d'utilisation

Publications (1)

Publication Number Publication Date
TN2009000211A1 true TN2009000211A1 (en) 2010-10-18

Family

ID=39383268

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2009000211A TN2009000211A1 (en) 2006-12-05 2009-05-29 Antiviral composition and method of use

Country Status (24)

Country Link
EP (1) EP2101792B1 (fr)
JP (1) JP5470047B2 (fr)
KR (1) KR101437708B1 (fr)
CN (1) CN101678040B (fr)
AT (1) ATE462438T1 (fr)
AU (1) AU2007327934B2 (fr)
BR (1) BRPI0720054A2 (fr)
CA (1) CA2671317C (fr)
CY (1) CY1110658T1 (fr)
DE (1) DE602007005697D1 (fr)
DK (1) DK2101792T3 (fr)
EA (1) EA015930B1 (fr)
ES (1) ES2343701T3 (fr)
HK (1) HK1141980A1 (fr)
IL (1) IL198810A (fr)
MA (1) MA31145B1 (fr)
MX (1) MX2009005838A (fr)
NO (1) NO342681B1 (fr)
NZ (1) NZ577063A (fr)
PL (1) PL2101792T3 (fr)
PT (1) PT2101792E (fr)
SI (1) SI2101792T1 (fr)
TN (1) TN2009000211A1 (fr)
WO (1) WO2008067982A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102065869B (zh) * 2008-07-01 2014-10-08 玛丽诺姆德生物技术公司 抗过敏的海洋生物聚合物
JP5702526B2 (ja) * 2009-04-30 2015-04-15 Ｅｓファイバービジョンズ株式会社 抗ウイルス性を有する硫酸化セルロースを担持させた繊維集合体
CN102652017A (zh) 2009-12-22 2012-08-29 玛丽诺姆德生物技术公司 协同抗病毒组合物及其应用
JP5900030B2 (ja) 2011-03-08 2016-04-06 凸版印刷株式会社 防湿容器
PT2898888T (pt) * 2014-01-22 2019-07-16 Visufarma B V Composição que compreende iota-carragenina contra conjuntivite viral
PT3370692T (pt) 2015-07-14 2023-07-18 Marinomed Biotech Ag Composição que elimina a congestão nasal e possui atividade antiviral
UA118192C2 (uk) * 2015-10-22 2018-12-10 Юрій Захарович Толчеєв Противірусна фармацевтична композиція
KR102316819B1 (ko) * 2018-04-20 2021-10-25 한미약품 주식회사 카라기난을 유효성분으로 포함하는 보존성이 개선된 액상 제제
KR101995376B1 (ko) * 2018-08-20 2019-07-02 한미약품 주식회사 카라기난을 유효성분으로 포함하는 항-바이러스 조성물
CN111437270A (zh) * 2020-04-24 2020-07-24 瑞希(重庆)生物科技有限公司 一种卡拉胶鼻用即型凝胶喷雾剂及其制备方法
KR20230094472A (ko) * 2021-12-21 2023-06-28 (주)메디코어 비강 세정제 조성물 및 그 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004505046A (ja) 2000-07-28 2004-02-19 イムファルム・アンパルトセルスカブ 感冒、アレルギー性鼻炎および気道に関連した感染症の症状の処置方法
US6953483B2 (en) * 2002-03-05 2005-10-11 Litke Kenneth S Aloe vera processed leather and leather gloves, garments, shoes and sandals made from aloe vera processed leather and a process for making aloe vera processed leather
WO2003093322A2 (fr) * 2002-04-30 2003-11-13 The Population Council, Inc. Formulations ameliorees de polysaccharide sulfate, leurs procedes, preparations et utilisations
CN1194981C (zh) * 2002-07-22 2005-03-30 青岛海洋大学 卡拉胶低聚糖的制备方法
CN101385741B (zh) * 2003-05-26 2012-05-16 福州大学 多糖硫酸酯作为制备抗流感病毒药物的应用
US20050009782A1 (en) * 2003-07-09 2005-01-13 Comper Wayne D. Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
WO2006003521A1 (fr) * 2004-02-06 2006-01-12 Monash University Utilisation a haute dose et sur un intervalle court de polysaccharides sulfates dans le traitement des infections
DE202005014019U1 (de) * 2005-09-05 2005-11-24 G. Pohl-Boskamp Gmbh & Co. Kg Zubereitung zum Ersatz von Speichelflüssigkeit und zur Pflege bei Trockenheit der Mund- und Rachenschleimhäute
ITRM20060115A1 (it) * 2006-03-06 2006-06-05 Paolo Ottier Guanto costituito da tre strati sovrapposti di poliuretano di cui due a tenuta stagna contenenti olio lubrificante per la parpazione del seno femminile
DE102006031812A1 (de) 2006-07-07 2008-01-17 Leoni Ag Sensorsystem und Sensorelement

Also Published As

Publication number Publication date
MX2009005838A (es) 2009-06-16
NO20091955L (no) 2009-09-04
IL198810A (en) 2013-03-24
NZ577063A (en) 2011-05-27
EA015930B1 (ru) 2011-12-30
WO2008067982A2 (fr) 2008-06-12
CN101678040A (zh) 2010-03-24
HK1141980A1 (en) 2010-11-26
EP2101792B1 (fr) 2010-03-31
PL2101792T3 (pl) 2010-11-30
DE602007005697D1 (de) 2010-05-12
PT2101792E (pt) 2010-06-25
EA200970529A1 (ru) 2009-12-30
CA2671317A1 (fr) 2008-06-12
DK2101792T3 (da) 2010-07-26
CA2671317C (fr) 2015-03-17
SI2101792T1 (sl) 2010-08-31
KR101437708B1 (ko) 2014-09-03
WO2008067982A3 (fr) 2009-04-16
EP2101792A2 (fr) 2009-09-23
JP5470047B2 (ja) 2014-04-16
IL198810A0 (en) 2010-02-17
KR20090096598A (ko) 2009-09-11
BRPI0720054A2 (pt) 2013-12-17
ATE462438T1 (de) 2010-04-15
AU2007327934A1 (en) 2008-06-12
CY1110658T1 (el) 2015-06-10
MA31145B1 (fr) 2010-02-01
JP2010512307A (ja) 2010-04-22
NO342681B1 (no) 2018-07-02
AU2007327934B2 (en) 2013-04-18
CN101678040B (zh) 2012-10-03
ES2343701T3 (es) 2010-08-06

Similar Documents

Publication Publication Date Title
IL198810A0 (en) Antiviral composition and method of use
MX2010007936A (es) Anticuerpo anti-nr-10 y su uso.
JO2858B1 (en) Pharmaceutical dosage images
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
ATE534391T1 (de) 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen
EP2099449A4 (fr) Composition pharmaceutique pour le traitement et la prévention d'affection impliquant l'impuissance
MX349787B (es) Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido.
TNSN08400A1 (en) Organic compounds and their uses
SG152237A1 (en) Pharmaceutical combinations containing benzoxazine for treating respiratory diseases
LTC2805723I2 (lt) Kladribino režimas, skirtas išsėtinei sklerozei gydyti
UA98299C2 (ru) Новая лекарственная форма рацекадотрила
TW200738700A (en) HIV integrase inhibitors
HK1093729A1 (en) Substituted quinolones
TNSN08496A1 (en) Aminothiazoles and their uses
UA88655C2 (ru) S-миртазапин для лечения прилива крови
WO2006089664A3 (fr) Imidazoles substitues par heterocyclylamide
UA94781C2 (ru) Применение йота-каррагенана для профилактики или терапевтического лечения риновирусной инфекции
BRPI0509667A (pt) azaquinazolinas substituìdas com eficácia antiviral
JO2730B1 (en) Medications for the treatment of endometriosis
CL2008002223A1 (es) Compuestos derivados de 9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a 2'-o-sustituida; proceso de preparación; compuesto intermediario; composición farmacéutica; y su uso en el tratamiento y/o profilaxis de la malaria.
WO2008157365A3 (fr) Procédés ou utilisations et compositions pour traiter ou empêcher la douleur neuropathique
MY166063A (en) Intravenous antiviral treatments
MX2009004237A (es) Uso de timosina alfa 1 para la preparacion de un medicamento para la prevencion y tratamiento de alergias.
UA39498U (ru) Способ лечения системной красной волчанки